| Symbol | MAIA |
|---|---|
| Name | MAIA BIOTECHNOLOGY, INC. |
| Sector | UNDEFINED |
| Region | UNDEFINED |
| Industry | Pharmaceutical Preparations |
| Address | 444 WEST LAKE STREET, SUITE 1700, CHICAGO, IL 60606 |
| Telephone | 312-416-8592 |
| Fax | — |
| — | |
| Website | — |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001878313 |
| Description | None |
New Form SCHEDULE 13G/A - MAIA Biotechnology, Inc. <b>Filed:</b> 2026-08-14 <b>AccNo:</b> 0001604867-26-000014 <b>Size:</b> 76 KB
Read moreMAIA Biotechnology Reports Strong Initial Efficacy Data in Third-Line Non-Small Cell Lung Cancer from Phase 2 THIO-101 Part C Expansion Trial
Read moreDirector CHAOUKI STEVEN M 🟢 acquired 27.0K shares (1 derivative) of MAIA Biotechnology, Inc. (MAIA) at $1.44 Transaction Date: Jun 30, 2026 | Filing ID: 000074
Read moreDirector Guerrero Ramiro 🟢 acquired 26.4K shares (1 derivative) of MAIA Biotechnology, Inc. (MAIA) at $1.44 Transaction Date: Jun 30, 2026 | Filing ID: 000073
Read moreDirector Louie Ngar Yee 🟢 acquired 32.6K shares (1 derivative) of MAIA Biotechnology, Inc. (MAIA) at $1.44 Transaction Date: Jun 30, 2026 | Filing ID: 000072
Read moreDirector Luput Cristian 🟢 acquired 27.6K shares (1 derivative) of MAIA Biotechnology, Inc. (MAIA) at $1.44 Transaction Date: Jun 30, 2026 | Filing ID: 000071
Read moreDirector Smith Stan 🟢 acquired 32.0K shares (1 derivative) of MAIA Biotechnology, Inc. (MAIA) at $1.44 Transaction Date: Jun 30, 2026 | Filing ID: 000070
Read moreMAIA Biotechnology Completes International Enrollment in Part C of Phase 2 THIO-101 Expansion Trial in Third-Line Non-Small Cell Lung Cancer
Read moreMAIA Biotechnology Opens Enrollment for Phase 2 Expansion Trial of Novel Telomere-Targeting Agent at Winship Cancer Institute of Emory University
Read moreMAIA Biotechnology Activates and Opens Enrollment at Second U.S. Clinical Site for International Phase 2 THIO-101 Expansion Trial
Read more